Started: 9/2019
Study Name A phase 2b, randomized, placebo-controlled, observer-blinded trial to evaluate the safety, tolerability, and immunogenicity of a respiratory syncytial virus (rsv) vaccine in pregnant women 18 through 49years of age and their infants
Indication: RSV/OB
Principal Investigator: Brad Brabec